Cargando…

SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier

The prevalence and specificity of unique fusion oncogenes are high in a number of soft tissue sarcomas (STSs). The close relationship between fusion genes and clinicopathological features suggests that a correlation may exist between the function of fusion proteins and cellular context of the cell-o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamaki, Sakura, Fukuta, Makoto, Sekiguchi, Kazuya, Jin, Yonghui, Nagata, Sanae, Hayakawa, Kazuo, Hineno, Sho, Okamoto, Takeshi, Watanabe, Makoto, Woltjen, Knut, Ikeya, Makoto, Kato, Tomohisa, Toguchida, Junya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646489/ https://www.ncbi.nlm.nih.gov/pubmed/26571495 http://dx.doi.org/10.1371/journal.pone.0142991

Ejemplares similares

Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes
por: Jin, Yonghui, et al.
Publicado: (2015)

Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma
por: Ishii, Midori, et al.
Publicado: (2018)

SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022)

The clinical implication of SS18-SSX fusion gene in synovial sarcoma
por: Ren, T, et al.
Publicado: (2013)

Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)

Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma
por: Raquib, Ainiah Rushdiana, et al.
Publicado: (2022)

Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma
por: Miura, Kentaro, et al.
Publicado: (2021)

Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells
por: Nakajima, Taiki, et al.
Publicado: (2018)

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
por: Przybyl, Joanna, et al.
Publicado: (2012)

Prognostic value of SS18–SSX fusion type in synovial sarcoma; systematic review and meta-analysis
por: Kubo, Tadahiko, et al.
Publicado: (2015)

Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression
por: Tanaka, Miwa, et al.
Publicado: (2020)

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
por: Cheng, Yanli, et al.
Publicado: (2022)

Derivation of Mesenchymal Stromal Cells from Pluripotent Stem Cells through a Neural Crest Lineage using Small Molecule Compounds with Defined Media
por: Fukuta, Makoto, et al.
Publicado: (2014)

Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin
por: Nasu, Akira, et al.
Publicado: (2013)

Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma
por: Przybyl, Joanna, et al.
Publicado: (2019)

A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
por: Li, Jinxiu, et al.
Publicado: (2021)

Myelin protein zero (P0)- and Wnt1-Cre marked muscle resident neural crest-derived mesenchymal progenitor cells give rise to heterotopic ossification in mouse models
por: Zhao, Chengzhu, et al.
Publicado: (2022)

β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
por: Barrott, Jared J., et al.
Publicado: (2015)

SYT-SSX fusion genes and prognosis in synovial sarcoma
por: Mezzelani, A, et al.
Publicado: (2001)

An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva
por: Hino, Kyosuke, et al.
Publicado: (2018)

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction
por: Di Mauro, Ilaria, et al.
Publicado: (2020)

Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
por: Peng, Changliang, et al.
Publicado: (2016)

Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review
por: Sasaki, Ken, et al.
Publicado: (2020)

The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
por: Cironi, Luisa, et al.
Publicado: (2016)

SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1
por: Minami, Yusuke, et al.
Publicado: (2014)

Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias
por: Pretemer, Yann, et al.
Publicado: (2021)

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
por: Maekawa, Hirotsugu, et al.
Publicado: (2020)

Collagen X Is Dispensable for Hypertrophic Differentiation and Endochondral Ossification of Human iPSC‐Derived Chondrocytes
por: Kamakura, Takeshi, et al.
Publicado: (2023)

The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1
por: Barco, Roy, et al.
Publicado: (2009)

Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability
por: Benabdallah, Nezha S., et al.
Publicado: (2023)

Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2
por: Garcia, Christina B, et al.
Publicado: (2012)

Deflection of vascular endothelial growth factor action by SS18–SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma
por: Wakamatsu, Toru, et al.
Publicado: (2014)

SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013)

Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research
por: Fricke, A., et al.
Publicado: (2016)

Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation
por: Alrubie, Turki M., et al.
Publicado: (2023)

Primary Pulmonary Biphasic Synovial Sarcoma Confirmed by Molecular Detection of a SYT-SSX2 Fusion Gene: Report of 1 Case
por: Park, Jae Seok, et al.
Publicado: (2010)

Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas
por: Komura, Shingo, et al.
Publicado: (2019)

SSX2IP helps the centrosome grow up
por: Leslie, Mitch
Publicado: (2013)

SSX addiction in melanoma propagates tumor growth and metastasis
por: Traynor, Sofie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgd7f9c4ajs2ds60v13rt7ora9